Strs Ohio purchased a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 40,300 shares of the company's stock, valued at approximately $218,000.
Other large investors have also recently added to or reduced their stakes in the company. Millennium Management LLC boosted its position in Aveanna Healthcare by 105.0% during the fourth quarter. Millennium Management LLC now owns 400,374 shares of the company's stock worth $1,830,000 after purchasing an additional 205,023 shares during the period. Deutsche Bank AG lifted its position in Aveanna Healthcare by 32.1% in the fourth quarter. Deutsche Bank AG now owns 34,564 shares of the company's stock worth $158,000 after purchasing an additional 8,396 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Aveanna Healthcare in the fourth quarter worth $223,000. Teacher Retirement System of Texas lifted its position in Aveanna Healthcare by 50.9% in the first quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company's stock worth $270,000 after purchasing an additional 16,835 shares during the period. Finally, Rhumbline Advisers lifted its position in Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock worth $410,000 after purchasing an additional 2,918 shares during the period. Institutional investors own 87.96% of the company's stock.
Wall Street Analyst Weigh In
AVAH has been the subject of several research reports. UBS Group raised Aveanna Healthcare from a "sell" rating to a "neutral" rating and raised their target price for the stock from $6.75 to $8.00 in a research report on Tuesday, August 19th. JPMorgan Chase & Co. raised Aveanna Healthcare from an "underweight" rating to a "neutral" rating and raised their target price for the stock from $6.00 to $10.00 in a research report on Thursday, September 18th. Wall Street Zen raised Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Barclays upgraded Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $5.50 to $9.50 in a research note on Tuesday, August 19th. Finally, Truist Financial dropped their price objective on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $7.92.
Get Our Latest Stock Analysis on Aveanna Healthcare
Aveanna Healthcare Price Performance
Aveanna Healthcare stock opened at $8.36 on Thursday. The stock has a fifty day moving average price of $6.61 and a two-hundred day moving average price of $5.54. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.67 and a 52-week high of $8.68. The firm has a market capitalization of $1.75 billion, a P/E ratio of 104.50 and a beta of 2.04.
About Aveanna Healthcare
(
Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.